why choose us

First received: April 06, 2023

Clinical Trial: Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers

Study Status: Completed

Recruit Status: RECRUITING

Condition: Metastatic Colorectal Carcinoma

Study Type: INTERVENTIONAL


Official Title: Phase I Trial of ZEN003694 (ZEN-3694) in Combination With Capecitabine in Patients With Solid Tumors

Brief Summary: This phase I trial tests the safety, side effects, and best dose of ZEN003694 in combination with the usual treatment with capecitabine in treating patients with cancer that has spread from where it first started (primary site) to other places in the body (metastatic) or cannot be removed by surgery (unresectable) and that it has progressed on previous standard treatment.ZEN003694 is an inhibitor of a family of proteins called the bromodomain and extra-terminal (BET).It may prevent the growth of tumor cells that…

Read more